Navigation Links
BioMed Realty Announces New Brand Identity

SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today unveiled a new brand identity that highlights the company's commitment to the life science industry by delivering state-of-the-art laboratories and office spaces to meet the unique needs of its tenants. The brand identity features an energetic new look comprised of a monogram logo in the stylized shape of the company's initials and NYSE ticker symbol, BMR, and a new tagline, Discover here™.

"BioMed Realty has experienced tremendous growth since our inception in 2004 through an unwavering dedication to our tenants and the leveraging of our specialty expertise in life science real estate to build valuable relationships that enable successes in the life science industry," said Alan D. Gold, the company's Chairman and Chief Executive Officer. "Our refreshed logo is inspired by a monogram which represents the heritage of a proven and pioneering business model executed by our skilled employees, the pride of ownership of our premier properties across the core U.S. life science markets and now Europe, and the values we share with our life science partners. To complement our modernized logo, we are pleased to introduce a new tagline, Discover here, which succinctly communicates the essence of our brand story and aspirations."

The monogram's interlocking letters symbolize BioMed Realty's innovative approach in support of its tenants' ongoing research and reflect the personal interaction and close relationships forged with tenants since the company was founded eight years ago. The tagline highlights the groundbreaking advancements in life science research occurring at BioMed Realty's properties, while inviting investors and life science professionals to learn how the company consistently creates long-term value.

Beginning today with the launch of a rebranded website at, which features enhanced navigation and access to multi-media content for the company's stakeholders, the transition to BioMed Realty's new brand identity will continue over the next several months.

Commenting on the implementation of the new brand identity, Kent Griffin, President of BioMed Realty, remarked, "Our new visual identity is designed to increase the company's brand recognition, which will help position BioMed Realty for continued growth. We are very excited about our refreshed brand and believe that this new visual identity accurately reflects our commitment to our tenants: turning our trusted expertise and reliable service into partnerships that contribute to life science industry successes."

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 13.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, San Diego, Maryland, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research.  Additional information is available at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing, the use of debt to fund acquisitions, developments and other investments, and the ability to refinance indebtedness as it comes due; failure to maintain the company's investment grade credit ratings with the ratings agencies; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; reductions in asset valuations and related impairment charges; risks and uncertainties affecting property development and construction; risks associated with downturns in foreign, domestic and local economies, changes in interest rates and foreign currency exchange rates, and volatility in the securities markets; ownership of properties outside of the United States that subject the company to different and potentially greater risks than those associated with the company's domestic operations; risks associated with the company's investments in loans, including borrower defaults and potential principal losses; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE BioMed Realty Trust, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
5. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
6. Live Press Briefing on Findings of Biomedical Industry CEO Survey
7. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
8. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
9. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
10. BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results
11. Minority Biomedical Entrepreneurship Conference
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ... Laurin , President and Chief Executive Officer of ProMetic, will ... 27 th Annual Healthcare Conference to be held at ... st , at 8.50am (ET) and ProMetic,s management ... The presentation will be available live via a webcast accessible ...
(Date:11/24/2015)... , November 24, 2015 , ... a European healthcare fund ... companies will work closely together in identifying European breakthrough technologies ... need. The collaboration is underpinned by a significant investment by ... is the first investment by Bristol-Myers Squibb in a European ...
(Date:11/23/2015)... 23, 2015   Ceres, Inc . (Nasdaq: ... results for the fiscal year ended August 31, 2015 ... --> --> During fiscal year ... feed products with a better balance of yield, energy ... agreements with several leading crop input providers and made ...
Breaking Biology Technology:
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
Breaking Biology News(10 mins):